Cross Country Healthcare, Inc. (CCRN)
USD 13.61
(0.59%)
USD 13.61
(0.59%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 2.01 Billion USD | -28.04% |
| 2022 | 2.8 Billion USD | 67.39% |
| 2021 | 1.67 Billion USD | 100.46% |
| 2020 | 836.41 Million USD | 1.73% |
| 2019 | 822.22 Million USD | 0.7% |
| 2018 | 816.48 Million USD | -5.61% |
| 2017 | 865.04 Million USD | 3.78% |
| 2016 | 833.53 Million USD | 8.62% |
| 2015 | 767.42 Million USD | 24.21% |
| 2014 | 617.82 Million USD | 40.96% |
| 2013 | 438.31 Million USD | -0.98% |
| 2012 | 442.63 Million USD | -12.17% |
| 2011 | 503.98 Million USD | 7.56% |
| 2010 | 468.56 Million USD | -18.97% |
| 2009 | 578.23 Million USD | -21.25% |
| 2008 | 734.24 Million USD | 2.22% |
| 2007 | 718.27 Million USD | 9.63% |
| 2006 | 655.15 Million USD | 1.51% |
| 2005 | 645.39 Million USD | -1.33% |
| 2004 | 654.11 Million USD | -4.78% |
| 2003 | 686.92 Million USD | 7.34% |
| 2002 | 639.95 Million USD | 27.86% |
| 2001 | 500.5 Million USD | 36.12% |
| 2000 | 367.68 Million USD | 89.75% |
| 1999 | 193.77 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 339.77 Million USD | -10.39% |
| 2024 Q1 | 379.17 Million USD | -8.42% |
| 2023 Q4 | 414.03 Million USD | -6.39% |
| 2023 Q3 | 442.29 Million USD | -18.2% |
| 2023 FY | 2.01 Billion USD | -28.04% |
| 2023 Q2 | 540.69 Million USD | -13.17% |
| 2023 Q1 | 622.7 Million USD | -0.88% |
| 2022 Q2 | 753.56 Million USD | -4.46% |
| 2022 FY | 2.8 Billion USD | 67.39% |
| 2022 Q4 | 628.21 Million USD | -1.24% |
| 2022 Q3 | 636.09 Million USD | -15.59% |
| 2022 Q1 | 788.73 Million USD | 23.11% |
| 2021 Q2 | 331.82 Million USD | 0.79% |
| 2021 Q1 | 329.24 Million USD | 52.7% |
| 2021 FY | 1.67 Billion USD | 100.46% |
| 2021 Q4 | 640.67 Million USD | 70.89% |
| 2021 Q3 | 374.9 Million USD | 12.98% |
| 2020 Q3 | 193.96 Million USD | -10.52% |
| 2020 Q2 | 216.77 Million USD | 3.2% |
| 2020 FY | 836.41 Million USD | 1.73% |
| 2020 Q4 | 215.6 Million USD | 11.16% |
| 2020 Q1 | 210.06 Million USD | -2.34% |
| 2019 FY | 822.22 Million USD | 0.7% |
| 2019 Q2 | 202.75 Million USD | 3.89% |
| 2019 Q3 | 209.2 Million USD | 3.18% |
| 2019 Q4 | 215.09 Million USD | 2.82% |
| 2019 Q1 | 195.17 Million USD | -2.86% |
| 2018 Q3 | 200.71 Million USD | -1.88% |
| 2018 Q2 | 204.57 Million USD | -2.72% |
| 2018 FY | 816.48 Million USD | -5.61% |
| 2018 Q1 | 210.28 Million USD | -4.27% |
| 2018 Q4 | 200.9 Million USD | 0.09% |
| 2017 Q1 | 207.57 Million USD | -6.72% |
| 2017 Q2 | 209.31 Million USD | 0.84% |
| 2017 FY | 865.04 Million USD | 3.78% |
| 2017 Q3 | 228.48 Million USD | 9.16% |
| 2017 Q4 | 219.67 Million USD | -3.86% |
| 2016 Q4 | 222.52 Million USD | 3.5% |
| 2016 FY | 833.53 Million USD | 8.62% |
| 2016 Q3 | 214.98 Million USD | 7.79% |
| 2016 Q1 | 196.58 Million USD | 1.78% |
| 2016 Q2 | 199.44 Million USD | 1.45% |
| 2015 Q4 | 193.14 Million USD | -1.3% |
| 2015 Q3 | 195.69 Million USD | 1.6% |
| 2015 FY | 767.42 Million USD | 24.21% |
| 2015 Q1 | 185.96 Million USD | -1.15% |
| 2015 Q2 | 192.61 Million USD | 3.58% |
| 2014 Q1 | 118.09 Million USD | 8.16% |
| 2014 FY | 617.82 Million USD | 40.96% |
| 2014 Q4 | 188.13 Million USD | -0.43% |
| 2014 Q3 | 188.94 Million USD | 54.04% |
| 2014 Q2 | 122.65 Million USD | 3.87% |
| 2013 Q2 | 110.76 Million USD | 0.41% |
| 2013 Q3 | 108.04 Million USD | -2.46% |
| 2013 Q4 | 109.17 Million USD | 1.05% |
| 2013 FY | 438.31 Million USD | -0.98% |
| 2013 Q1 | 110.31 Million USD | -1.27% |
| 2012 Q2 | 126.27 Million USD | -0.32% |
| 2012 Q3 | 129.12 Million USD | 2.26% |
| 2012 Q4 | 111.73 Million USD | -13.47% |
| 2012 Q1 | 126.67 Million USD | 1.56% |
| 2012 FY | 442.63 Million USD | -12.17% |
| 2011 Q4 | 124.72 Million USD | -4.91% |
| 2011 FY | 503.98 Million USD | 7.56% |
| 2011 Q2 | 126.04 Million USD | 3.27% |
| 2011 Q1 | 122.04 Million USD | 7.36% |
| 2011 Q3 | 131.16 Million USD | 4.07% |
| 2010 Q4 | 113.67 Million USD | -1.74% |
| 2010 Q1 | 121.36 Million USD | -2.24% |
| 2010 Q2 | 117.83 Million USD | -2.9% |
| 2010 Q3 | 115.68 Million USD | -1.82% |
| 2010 FY | 468.56 Million USD | -18.97% |
| 2009 Q4 | 124.13 Million USD | -4.24% |
| 2009 FY | 578.23 Million USD | -21.25% |
| 2009 Q1 | 175.41 Million USD | -14.81% |
| 2009 Q2 | 149.04 Million USD | -15.03% |
| 2009 Q3 | 129.63 Million USD | -13.02% |
| 2008 Q4 | 205.91 Million USD | 15.59% |
| 2008 FY | 734.24 Million USD | 2.22% |
| 2008 Q3 | 178.13 Million USD | 4.2% |
| 2008 Q2 | 170.95 Million USD | -4.63% |
| 2008 Q1 | 179.25 Million USD | -1.36% |
| 2007 Q2 | 175.33 Million USD | -0.43% |
| 2007 Q4 | 181.71 Million USD | -1.84% |
| 2007 Q1 | 176.09 Million USD | 0.2% |
| 2007 Q3 | 185.12 Million USD | 5.58% |
| 2007 FY | 718.27 Million USD | 9.63% |
| 2006 FY | 655.15 Million USD | 1.51% |
| 2006 Q4 | 175.74 Million USD | 7.9% |
| 2006 Q1 | 159.83 Million USD | -3.59% |
| 2006 Q2 | 156.69 Million USD | -1.96% |
| 2006 Q3 | 162.87 Million USD | 3.94% |
| 2005 Q1 | 158.03 Million USD | 5.98% |
| 2005 FY | 645.39 Million USD | -1.33% |
| 2005 Q2 | 159 Million USD | 0.61% |
| 2005 Q3 | 162.57 Million USD | 2.25% |
| 2005 Q4 | 165.78 Million USD | 1.98% |
| 2004 FY | 654.11 Million USD | -4.78% |
| 2004 Q2 | 167.3 Million USD | -3.07% |
| 2004 Q3 | 165.07 Million USD | -1.34% |
| 2004 Q4 | 149.12 Million USD | -9.66% |
| 2004 Q1 | 172.61 Million USD | -1.72% |
| 2003 Q2 | 165.91 Million USD | 3.05% |
| 2003 Q3 | 184.38 Million USD | 11.14% |
| 2003 Q4 | 175.62 Million USD | -4.75% |
| 2003 FY | 686.92 Million USD | 7.34% |
| 2003 Q1 | 161 Million USD | -6.1% |
| 2002 Q2 | 155.97 Million USD | 0.72% |
| 2002 Q3 | 157.65 Million USD | 1.08% |
| 2002 Q1 | 154.86 Million USD | 7.31% |
| 2002 FY | 639.95 Million USD | 27.86% |
| 2002 Q4 | 171.45 Million USD | 8.76% |
| 2001 FY | 500.5 Million USD | 36.12% |
| 2001 Q2 | 111.35 Million USD | 0.0% |
| 2001 Q1 | 111.35 Million USD | 0.0% |
| 2001 Q3 | 133.48 Million USD | 19.88% |
| 2001 Q4 | 144.3 Million USD | 8.11% |
| 2000 FY | 367.68 Million USD | 89.75% |
| 1999 FY | 193.77 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 2.92 Billion USD | 31.038% |
| Addus HomeCare Corporation | 1.05 Billion USD | -90.783% |
| AirSculpt Technologies, Inc. | 195.91 Million USD | -930.91% |
| Amedisys, Inc. | 2.23 Billion USD | 9.688% |
| Astrana Health, Inc. | 1.38 Billion USD | -45.654% |
| Aveanna Healthcare Holdings Inc. | 1.89 Billion USD | -6.57% |
| IMAC Holdings, Inc. | 5.19 Million USD | -38763.344% |
| biote Corp. | 185.36 Million USD | -989.625% |
| Cryo-Cell International, Inc. | 31.34 Million USD | -6343.81% |
| COMPASS Pathways plc | - USD | -Infinity% |
| DocGo Inc. | 624.28 Million USD | -223.525% |
| The Ensign Group, Inc. | 3.72 Billion USD | 45.842% |
| Healthcare Services Group, Inc. | 1.67 Billion USD | -20.841% |
| InnovAge Holding Corp. | 763.85 Million USD | -164.412% |
| The Joint Corp. | 117.69 Million USD | -1616.05% |
| LifeStance Health Group, Inc. | 1.05 Billion USD | -91.323% |
| Mobile-health Network Solutions Class A Ordinary Shares | 10.35 Million USD | -19398.235% |
| ModivCare Inc. | 2.75 Billion USD | 26.587% |
| NewGenIvf Group Limited | 5.13 Million USD | -39223.751% |
| Option Care Health, Inc. | 4.3 Billion USD | 53.055% |
| P3 Health Partners Inc. | 1.26 Billion USD | -59.489% |
| P3 Health Partners Inc. | 1.26 Billion USD | -59.489% |
| The Pennant Group, Inc. | 544.89 Million USD | -270.666% |
| Surgery Partners, Inc. | 2.74 Billion USD | 26.376% |
| Syra Health Corp. Class A Common Stock | 5.51 Million USD | -36521.492% |
| Talkspace, Inc. | 150.04 Million USD | -1246.082% |
| Talkspace, Inc. | 150.04 Million USD | -1246.082% |
| The Oncology Institute, Inc. | 324.23 Million USD | -522.913% |
| The Oncology Institute, Inc. | 324.23 Million USD | -522.913% |